The effect of isoprinosine in subacute sclerosing panencephalitis (SSPE)

Leopold Streletz, J. Cracco

Research output: Contribution to journalArticle

23 Citations (Scopus)


Although no therapeutic agent has proved to be of benefit in subacute sclerosing panencephalitis (SSPE), the use of Isoprinosine has been associated with clinical improvement in several preliminary reports. Two additional patients with SSPE are presented who had repeated serological and electroencephalographic studies during therapy with Isoprinosine. Their clinical courses are discussed in view of the laboratory findings and the natural history of the disease.

Original languageEnglish
Pages (from-to)183-184
Number of pages2
JournalAnnals of Neurology
Issue number2
Publication statusPublished - 1977
Externally publishedYes


ASJC Scopus subject areas

  • Medicine(all)
  • Neurology
  • Clinical Neurology

Cite this